Acupressure Therapy: Evidence-Based Guide to Pressure Point Healing — Cost, Top Hospitals & Success Rates | MyMedicPlus

Acupressure is a therapeutic modality rooted in Traditional Chinese Medicine (TCM) that involves applying firm, sustained manual pressure to specific points on the body — known as acupoints or xue — along pathways called meridians or channels (jing luo). Unlike acupuncture, acupressure requires no needles: pressure is applied with the fingers, thumbs, or specialised devices, making it accessible for both clinical practice and self-administration.

According to TCM theory, the body's vital energy (qi) flows along 12 principal meridians and 8 extraordinary channels, connecting the body's organs, tissues, and surface. Illness results from disrupted, deficient, or excessive qi flow. Stimulating acupoints is believed to restore balance and promote the free circulation of qi and blood. While this theoretical framework has no established mechanism in Western biomedical science, clinical research has identified measurable physiological effects of acupoint stimulation — including modulation of the autonomic nervous system, endorphin release, and serotonin pathway activation — which may partially explain observed therapeutic effects independent of the traditional theoretical model.

Acupressure has been practised for at least 2,000 years, with descriptions in the Huangdi Neijing (Yellow Emperor's Classic of Internal Medicine). Related traditions include shiatsu — a Japanese acupressure system that integrates meridian pressure with stretching — and Tui Na, a Chinese manual therapy that combines acupressure with massage and joint mobilisation techniques. Reflexology, while sometimes grouped with acupressure, is a distinct modality focused on reflex zones on the feet, hands, and ears, without a shared theoretical basis with TCM meridian theory.

In modern integrative medicine, acupressure occupies a unique position as one of the better-evidenced complementary therapies, particularly for chemotherapy-induced and postoperative nausea and vomiting, where clinical evidence supports its use alongside conventional treatment.

Acupressure has been studied and used across a range of clinical conditions. The strength of evidence varies considerably, from well-supported indications to those based primarily on traditional use:

Chemotherapy-induced nausea and vomiting (CINV):

The strongest evidence base for acupressure relates to CINV. The PC6 (Pericardium 6 / Neiguan) point, located on the inner wrist approximately 3 finger-breadths above the wrist crease, is the primary acupoint studied. A Cochrane systematic review (Ezzo et al., 2006; updated analyses) found that PC6 stimulation — including manual acupressure and wristband devices — reduces acute CINV with a risk ratio of 0.68 (95% CI 0.57–0.81) compared to control groups. The ASCO Integrative Oncology Clinical Practice Guidelines (2023 update) recommend acupressure (and acupuncture) as beneficial for managing CINV alongside standard antiemetic prophylaxis.

Postoperative nausea and vomiting (PONV):

PC6 stimulation via wristband (Sea-Band) and transcutaneous electrical acupoint stimulation (ReliefBand device) has demonstrated efficacy in multiple RCTs for PONV. Meta-analyses confirm a statistically significant reduction in postoperative nausea incidence, comparable in some studies to ondansetron.

Dysmenorrhoea (primary):

SP6 (Spleen 6 / Sanyinjiao), located 3 cun (finger-widths) above the medial malleolus on the posterior tibial border, has been studied for primary dysmenorrhoea. A 2016 systematic review and meta-analysis found that SP6 acupressure significantly reduced pain intensity and duration compared to control, with a standardised mean difference favouring acupressure.

Other studied conditions:

• Headache and migraine — LI4 (Large Intestine 4 / Hegu), located in the web space between the thumb and index finger
• Labour pain and anxiety — auricular acupressure and SP6 stimulation
• Nausea and vomiting of pregnancy (NVP) — PC6 wristbands
• Gastrointestinal dysmotility and functional dyspepsia — ST36 (Stomach 36 / Zusanli), located below the knee
• Generalised anxiety and insomnia — HT7 (Heart 7 / Shenmen) and auricular points

Acupressure is broadly applicable across most patient populations and is one of the safest complementary therapies available. Its eligibility criteria are defined more by precautions and contraindications than by exclusive inclusion criteria.

Conditions where acupressure is well-supported and appropriate:

• Cancer patients receiving chemotherapy experiencing CINV — supported by ASCO 2023 integrative oncology guidelines
• Post-surgical patients experiencing PONV seeking non-pharmacological adjuncts to standard antiemetics
• Women with primary dysmenorrhoea seeking non-pharmacological pain management
• Pregnant women experiencing nausea in the first trimester (PC6 wristbands are widely used and considered safe)
• Patients with chronic headache or migraine as part of a multimodal pain management programme
• Patients seeking self-management tools for anxiety, insomnia, or gastrointestinal discomfort

Precautions — exercise caution in:

• Patients on anticoagulants or with bleeding disorders — deep, prolonged pressure over bony prominences may cause localised bruising
• Skin conditions, open wounds, burns, or active infection overlying acupoints — avoid direct pressure on affected skin
• Severe osteoporosis — avoid deep pressure over vertebral and rib acupoints
• Recent surgery — avoid pressure over incision sites
• Cancer patients with bone metastases — avoid direct pressure over metastatic sites

Pregnancy cautions: While PC6 is safe in pregnancy and widely used for NVP, certain acupoints are traditionally considered contraindicated in pregnancy due to theoretical risk of stimulating uterine contractions. These include SP6, LI4, GB21, and BL60. Until further evidence clarifies the clinical significance of these restrictions, caution is advised. Pregnant women should inform their practitioner of their pregnancy before commencing acupressure.

No special eligibility requirements: Unlike acupuncture, acupressure requires no clinical setting and can be self-administered after instruction, making it particularly suitable for ongoing self-management of recurrent symptoms such as CINV, travel sickness, or headache.

Acupressure can be delivered through several modes — professional clinical treatment, self-administered techniques, and wearable devices. The approach chosen depends on the clinical indication, patient preference, and available resources.

1. Professional Acupressure Sessions

A qualified practitioner (Traditional Chinese Medicine practitioner, acupressurist, or physiotherapist trained in acupressure) applies sustained digital pressure to relevant acupoints for 30–60 seconds per point, repeated 3–5 times per session. Sessions typically last 30–60 minutes. For chronic conditions, a course of 6–10 weekly sessions is recommended initially, followed by maintenance sessions. Practitioners may combine acupressure with TCM diagnosis, dietary advice, and herbal recommendations.

2. Shiatsu

A Japanese manual therapy based on TCM meridian theory. The practitioner applies rhythmic pressure with thumbs, palms, and sometimes elbows and knees along meridian pathways, combined with gentle joint mobilisation and stretching. Sessions are typically performed on a floor mat with the patient fully clothed. Shiatsu is used for stress reduction, musculoskeletal pain, and general wellness.

3. Tui Na (Chinese Manual Therapy)

A TCM manual therapy combining acupoint stimulation with massage, joint manipulation, and soft tissue techniques. More clinically oriented than shiatsu, Tui Na practitioners treat specific musculoskeletal conditions and internal disorders as part of integrated TCM treatment plans.

4. Self-Acupressure Techniques

For PC6 (Neiguan) — nausea: locate the point 3 finger-breadths above the wrist crease, between the two central tendons (palmaris longus and flexor carpi radialis). Apply firm pressure with the thumb of the opposite hand for 2–3 minutes, breathing slowly. For LI4 (Hegu) — headache/pain: locate the highest point of the muscle belly between the thumb and index finger on the dorsum of the hand. Apply firm downward pressure for 2–3 minutes. For SP6 (Sanyinjiao) — dysmenorrhoea: locate 3 cun above the medial malleolus on the posterior tibia border. Apply upward pressure for 2–3 minutes.

5. Wearable Acupressure Devices

Sea-Band wristbands (elastic bands with a plastic button positioned over PC6) are widely available over the counter and have clinical evidence for PONV and NVP. The ReliefBand is a transcutaneous electrical acupoint stimulator applied to PC6 with FDA clearance for NVP and PONV. These devices provide sustained PC6 stimulation without requiring manual pressure.

Acupressure stands out among complementary therapies for having a meaningful and growing evidence base in specific clinical indications, particularly nausea management:

Chemotherapy-induced nausea and vomiting (CINV):

The 2006 Cochrane review (Ezzo et al.) — the most comprehensive meta-analysis of acupoint stimulation for CINV — found that PC6 stimulation significantly reduced the proportion of patients experiencing acute vomiting (risk ratio 0.82, 95% CI 0.69–0.99) and nausea (standardised mean difference -0.19, 95% CI -0.37 to -0.01) in RCTs of PC6 wristbands and manual acupressure, compared to sham or no treatment controls. The ASCO Integrative Oncology Clinical Practice Guidelines (2023 update) now recommend acupressure and acupuncture as beneficial — alongside standard antiemetics — for adults with cancer experiencing CINV.

Postoperative nausea and vomiting (PONV):

A 2009 Cochrane review by Lee et al. of 40 RCTs found that PC6 acupoint stimulation (manual, wristband, or electrical) significantly reduced PONV risk compared to sham control, with results comparable to a single dose of commonly used antiemetic drugs. Sea-Band wristbands and ReliefBand devices are routinely incorporated into multimodal PONV prevention protocols at many anaesthesia departments.

Dysmenorrhoea:

A systematic review and meta-analysis (Chen and Chen, 2016) of 6 RCTs found SP6 acupressure significantly reduced both pain severity (VAS scores) and pain duration compared to sham acupressure, with effects persisting across menstrual cycles during treatment. Effects were comparable to ibuprofen in some studies.

General benefits of acupressure therapy:

• Non-pharmacological — no systemic drug effects or interactions
• Empowers self-management through teachable techniques
• No significant adverse events reported in clinical trials
• Compatible with and adjunctive to conventional treatment
• Accessible via wearable devices (PC6) for continuous, non-clinical-setting use
• Effective for nausea in pregnancy (no drug exposure concerns)

Acupressure has an excellent safety profile. It is one of the safest complementary therapies, with no serious adverse events reported in published clinical trials to date. Adverse effects, when they occur, are almost universally mild and transient:

Commonly reported minor adverse effects:

• Localised bruising or tenderness at pressure sites — particularly in patients on anticoagulants or with fragile skin
• Transient skin redness or mild discomfort at the point of applied pressure
• Wristband-related effects (Sea-Band): mild skin irritation under the band during prolonged wear; contact dermatitis in latex-sensitive individuals (rare)
• Dizziness or lightheadedness during or immediately after a session — particularly in those with low blood pressure or who have not eaten
• Emotional release — some patients experience unexpected emotional responses during and after acupressure sessions, which practitioners attribute to the release of suppressed stress responses

Pregnancy:

Certain acupoints (SP6, LI4, GB21, BL60) are traditionally avoided during pregnancy due to the theoretical concern that strong stimulation may trigger uterine contractions. The clinical evidence for this risk is not well established, but the precautionary principle applies. PC6 stimulation for NVP is widely used throughout pregnancy and is considered safe at typical wristband pressures.

Medical device considerations:

The ReliefBand transcutaneous electrical device should not be used by patients with cardiac pacemakers or implantable cardiac defibrillators (ICDs) without cardiologist approval, as transcutaneous electrical stimulation may theoretically interfere with device function. This applies broadly to all TENS-type devices.

Delayed medical care:

The most significant clinical risk of acupressure is not the therapy itself, but the potential for patients to use it in place of timely conventional medical care for serious conditions. Acupressure should be used as a complementary approach alongside, not instead of, conventional treatment. CINV, for example, may be a sign of inadequate antiemetic prophylaxis requiring pharmacological adjustment.

Follow-up after acupressure depends on the clinical indication and whether it is being used as part of a professional treatment programme or as self-administered symptom management.

For professional treatment programmes:

• Initial clinical assessment by the practitioner to identify relevant acupoints based on the patient's symptoms, TCM pattern diagnosis, and treatment goals
• A typical course of 6–10 weekly sessions is recommended for chronic conditions (chronic pain, anxiety, dysmenorrhoea); improvement is generally expected by sessions 3–4
• Formal reassessment of treatment goals and outcomes at the end of the initial course, with continuation, modification, or discharge as appropriate
• Maintenance sessions (monthly or as needed) for conditions prone to recurrence

For self-acupressure:

• No specific follow-up schedule is required; the technique can be used on demand
• PC6 wristbands can be worn continuously during periods of nausea risk (chemotherapy cycles, travel, perioperative period) and removed at other times
• Patients using acupressure for CINV should maintain standard antiemetic prescriptions and report inadequate nausea control to their oncology team, who may adjust pharmacological prophylaxis

Outcome monitoring: For clinical research purposes and practitioner assessment, validated outcome measures are used including the Functional Living Index — Emesis (FLIE) for CINV, visual analogue scales (VAS) for pain, and the Hospital Anxiety and Depression Scale (HADS) for psychological outcomes. In clinical practice, patient-reported outcome measures and symptom diaries provide useful data to guide treatment continuation.

Integration with oncology care: Patients using acupressure as part of cancer supportive care should inform their oncologist and ensure the acupressure practitioner is aware of the cancer diagnosis, current treatments, and any relevant contraindications (e.g., bone metastases, thrombocytopenia, anticoagulation). Many cancer centres now offer integrative oncology consultations where this coordination occurs within a multidisciplinary framework.

Acupressure is one of the more cost-accessible complementary therapies, particularly given the availability of self-administration techniques and low-cost wearable devices.

Professional treatment sessions:

• UK: TCM practitioner acupressure sessions typically cost £40–£80 per session; shiatsu practitioners charge £50–£90; Tui Na practitioners £40–£75. NHS provision of acupressure is limited but available through some integrated pain management services and oncology supportive care programmes.
• USA: Acupressure/acupuncture sessions at integrative medicine centres cost $75–$150 per session. Some cancer centres (e.g., Memorial Sloan Kettering, MD Anderson) offer integrative oncology acupressure as part of supportive care — sometimes covered by cancer care packages.
• India: TCM and Ayurvedic acupressure sessions are widely available at $5–$20 equivalent per session at qualified practitioners; shiatsu and Tui Na are available at urban wellness centres at $10–$40.

Self-administered devices:

• Sea-Band wristbands (PC6 acupressure): widely available at pharmacies and online for approximately £8–£15 ($10–$20) per pair; reusable and highly cost-effective for ongoing CINV or NVP management.
• ReliefBand device: approximately $100–$180 for the rechargeable version; FDA-cleared for nausea; higher upfront cost but reusable across multiple chemotherapy cycles or pregnancies.

Insurance and coverage: In most Western countries, acupressure and acupuncture are not universally covered by standard health insurance. However, coverage is expanding: some US health plans include acupuncture for chronic low back pain (following NICE and ACP guideline endorsements), and cancer-specific supplemental insurance plans sometimes include integrative oncology services. In Germany, statutory health insurance (GKV) covers acupuncture for chronic back pain and osteoarthritis of the knee.

Medical tourism: For patients seeking traditional acupressure or Tui Na within a comprehensive TCM programme, China, Thailand, and India offer high-quality residential integrative medicine retreats at a fraction of Western costs.

Acupressure is most appropriately used as part of a multimodal approach. Several evidence-based alternatives address the same indications:

For chemotherapy-induced nausea and vomiting:

• Pharmacological antiemetics (first-line): The 5-HT3 antagonist ondansetron, NK1 receptor antagonist aprepitant, and dexamethasone form the evidence-based "triple therapy" backbone for highly emetogenic chemotherapy per MASCC/ESMO 2016 guidelines. These are not alternatives to acupressure — they are the standard of care with which acupressure is combined as an adjunct.
• Acupuncture: Needle-based stimulation of PC6 and other acupoints has a comparable or slightly larger effect size than acupressure for CINV in meta-analyses. ASCO 2023 guidelines recommend both. The choice between acupuncture and acupressure depends on patient preference, needle tolerance, and access to qualified practitioners.
• Ginger (Zingiber officinale): Has modest evidence for CINV at doses of 0.5–1 g per day; included in some integrative oncology protocols. Generally safe and may be combined with acupressure.

For dysmenorrhoea:

• NSAIDs (ibuprofen, naproxen, mefenamic acid) remain the most effective pharmacological treatment for primary dysmenorrhoea, reducing prostaglandin-mediated uterine cramping.
• Combined oral contraceptive pill for longer-term hormonal management.
• TENS (transcutaneous electrical nerve stimulation) — high-frequency TENS has RCT evidence for pain reduction in dysmenorrhoea.
• Heat therapy (local abdominal heat application) — moderate evidence as an adjunct.

For headache and chronic pain:

• Acupuncture has stronger evidence than acupressure for chronic headache, tension-type headache, and migraine prevention — recommended in NICE guidelines (NG150) for chronic primary headache when pharmacological prevention is contraindicated or ineffective.
• TENS, physiotherapy, and cognitive-behavioural pain management for chronic musculoskeletal pain.

Patients are advised to discuss all complementary therapies with their primary care physician or specialist to ensure safe integration with their overall treatment plan.